SCR-LIP-000619 · Claim · machine-readable JSON →
Neuropathic pain features are frequently reported in lipedema and may be more common in advanced stages.
General proposition consolidated from 4 earlier single-paper claims; each study's own result is shown as its finding.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 4 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-11-20 → 2026-11-20
Structured evidence, machine-compiled — not a verdict.
Evidence over time
Evidence (4)
- Neuropathic Pain Features in Lipedema Compared to Lymphedema: An Exploratory Cross-Sectional Study. — Pervane S, Uzun Ö. (2026) ✓ verified — consistent · cross sectional · 2026 · reading confidence: high
In 118 women, lipedema patients had higher pain severity (VAS 6.2 vs 5.5, p=0.02) and neuropathic pain prevalence (42% vs 21%, p<0.01) than lymphedema patients.
The article documents a high burden of neuropathic chronic pain features and associated anxiety/catastrophizing in lipedema, supporting an association with chronic-pain phenomena, but it does not test fibromyalgia specifically, so it refine - Multidimensional Assessment of Pain and Related Factors In Lipedema: A Controlled Clinical Study. — Gümrük Aslan S, Barış Saklica Ş, Borman P. (2026) ✓ verified — consistent · cross sectional · 2026 · reading confidence: high
“Patients with lipedema demonstrated clinically relevant pain and neuropathic pain features.”
In 20 women with lipedema vs 20 healthy controls, lipedema patients showed clinically relevant pain and neuropathic pain features (VAS, LANSS, DN4); LANSS correlated with VAS (rho=0.529).
The study characterizes pain and neuropathic pain in lipedema but does not test association with fibromyalgia or other named chronic-pain conditions, so it is on-topic background rather than a direct test of the comorbidity relationship. - Screening for lipedema in women with lower extremity pain and its associations with functional status, pain, mood, and quality of life: A questionnaire-based case–control study (2026) ✓ verified — consistent · case control · 2026 · reading confidence: high
“Mulheres com dor em membros inferiores tiveram escores de LSQ maiores e mais lipedema provável que controles (36,8% contra 12,3%; p = 0,001)”
Among women with lower extremity pain, probable lipedema was more frequent than in controls (36.8% vs 12.3%, p=0.001); PainDETECT independently associated with LSQ score (beta=0.382, p=0.004).
Study links lipedema probability with chronic lower-extremity and neuropathic pain, supporting an association, but it is screening-based (LSQ not diagnostic) and addresses neuropathic pain rather than fibromyalgia specifically, so it refine - Indications of Peripheral Pain, Dermal Hypersensitivity, and Neurogenic Inflammation in Patients with Lipedema — Chakraborty et al. (2022) ✓ verified — refining · cross sectional · 2022 · reading confidence: high
“painDETECT cumulativo: 11,0±5,2 (S1) vs 10,5±4,9 (S2) vs 17,6±7,2 (S3); p=0,0271; apenas Stage 3 apresentou respondedores >19 (dor neuropática)”
painDETECT scores were higher in stage 3 (17.6) than stages 1-2 (11.0, 10.5; p=0.0271), with neuropathic responders only in stage 3; cutaneous hypersensitivity and CGRP/NGF increased with stage.
The article characterizes pain mechanisms (peripheral neuropathic pain, dermal hypersensitivity, neurogenic inflammation) within lipedema across stages, supporting lipedema as a chronic-pain condition, but it does not examine fibromyalgia o
Context (PECO)
Answers these questions
Gaps & caveats
Change log
- 2026-11-20 — created_by_consolidation · general proposition consolidated from SQ-LIP-000008